Welichem Biotech Inc. (WBI)

Welichem Biotech Inc.

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:TSXV:WBI

1

Date	Time	Source	Headline	Symbol	Company
22/07/2014	22:19	PR Newswire (Canada)	Welichem Announces Termination of Asset Purchase Agreement and Update on Compulsory Acquisition	TSXV:WBI	Welichem Biotech Inc.
30/06/2014	23:38	PR Newswire (Canada)	Welichem Responds to completion of Take-over Bid	TSXV:WBI	Welichem Biotech Inc.
27/06/2014	17:21	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - WBI	TSXV:WBI	Welichem Biotech Inc.
27/06/2014	17:21	PR Newswire (Canada)	IIROC Trading Halt - WBI	TSXV:WBI	Welichem Biotech Inc.
03/06/2014	01:23	PR Newswire (Canada)	Welichem's Directors Affirm Recommendation that Shareholders Reject LJ Resources Co., Ltd. Offer	TSXV:WBI	Welichem Biotech Inc.
30/04/2014	00:25	PR Newswire (Canada)	Welichem's Directors Recommend Shareholders Reject LJ Resources Co., Ltd. Offer	TSXV:WBI	Welichem Biotech Inc.
17/04/2014	00:01	PR Newswire (Canada)	Welichem Responds to filing of Take-over Bid Circular	TSXV:WBI	Welichem Biotech Inc.
02/01/2014	22:59	PR Newswire (Canada)	Welichem Announces Changes of Directors	TSXV:WBI	Welichem Biotech Inc.
10/10/2013	05:01	PR Newswire (Canada)	Welichem announces substantial issuer bid	TSXV:WBI	Welichem Biotech Inc.
30/08/2013	08:01	PR Newswire (Canada)	Welichem announces substantial issuer bid	TSXV:WBI	Welichem Biotech Inc.
28/03/2013	22:57	PR Newswire (Canada)	Welichem Biotech Inc. enters into agreement to acquire rights to WBI-1001 in China, Taiwan, Macao and Hong Kong	TSXV:WBI	Welichem Biotech Inc.
02/03/2013	00:35	PR Newswire (Canada)	Welichem announces the Resignation of Lijuan Pang as a Director	TSXV:WBI	Welichem Biotech Inc.
29/07/2012	08:56	PR Newswire (Canada)	Welichem and Stiefel, a GSK company, complete the acquisition by Stiefel of the novel anti-inflammatory agent, WBI-1001	TSXV:WBI	Welichem Biotech Inc.
04/07/2012	13:15	PR Newswire (Canada)	Welichem shareholders approve asset purchase agreement with Stiefel, a GSK company	TSXV:WBI	Welichem Biotech Inc.
29/05/2012	11:33	PR Newswire (Canada)	IIROC Trading Halt - WBI	TSXV:WBI	Welichem Biotech Inc.
29/05/2012	04:14	PR Newswire (Canada)	IIROC Trading Resumption - WBI	TSXV:WBI	Welichem Biotech Inc.
29/05/2012	04:04	PR Newswire (Canada)	Stiefel, a GSK company, enters into an agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and	TSXV:WBI	Welichem Biotech Inc.
28/05/2012	08:16	PR Newswire (Canada)	Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic	TSXV:WBI	Welichem Biotech Inc.
02/02/2011	18:56	PR Newswire (Canada)	WELICHEM SUCCESSFULLY COMPLETES TWO PHASE II CLINICAL TRIALS OF WBI-1001 CREAM IN PATIENTS WITH PSORIASIS AND ATOPIC DERMATITIS	TSXV:WBI	Welichem Biotech Inc.
12/07/2010	21:20	Marketwired Canada	TSX Venture Exchange Daily Bulletins for July 12, 2010	TSXV:WBI	Welichem Biotech Inc.
15/09/2009	21:41	Marketwired Canada	TSX Venture Exchange Daily Bulletins for September 15, 2009	TSXV:WBI	Welichem Biotech Inc.
02/09/2009	22:13	Marketwired Canada	TSX Venture Exchange Daily Bulletins for September 2, 2009	TSXV:WBI	Welichem Biotech Inc.
20/06/2008	21:52	Marketwired Canada	TSX Venture Exchange Daily Bulletins for June 20, 2008	TSXV:WBI	Welichem Biotech Inc.
19/06/2008	22:27	Marketwired Canada	TSX Venture Exchange Daily Bulletins for June 19, 2008	TSXV:WBI	Welichem Biotech Inc.